Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedApr 19, 2017Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use OnlyChemical ContaminationNovel Laboratories, Inc. · D-0653-2017Class IIITerminatedApr 19, 2017Penicillin V Potassium TabletsPresence of Foreign Tablet/Capsule; Amoxicillin 500 mg was found in bottles of Penicillin V potassium 500 mgCitron Pharma Llc · D-0652-2017Class IIITerminatedApr 19, 2017Doxercalciferol Capsules 0.5mcgFailed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.West-Ward Columbus, Inc. · D-0651-2017Class IIITerminatedApr 12, 2017Quinapril Tablets USP 5 mgFailed Impurities/Degradation Specifications; Impurity ALupin Pharmaceuticals Inc. · D-0650-2017Class IIITerminatedApr 12, 2017RIVASTIGMINE Tartrate CapsulesCross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.Dr. Reddy's Laboratories, Inc. · D-0649-2017Class IITerminatedApr 12, 2017CotellicSuperpotent Drug: An oversized tablet was found in a bottle.Genentech Inc. · D-0648-2017Class IIITerminatedApr 12, 2017Fluphenazine Decanoate InjectionSubpotent DrugFresenius Kabi USA, LLC · D-0647-2017Class ITerminatedApr 12, 2017XtraHRD Natural Male Enhancement CapsulesMarketed without an Approved NDA/ANDA: Product contains N-desmethyl tadalafil an analogue to tadalafil which is an active pharmaceutical ingredient in a FDA approved...Organic Herbal Supply · D-0646-2017Class ITerminatedApr 12, 2017Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0645-2017Class ITerminatedApr 12, 2017Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0644-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Total Approximate Volume 515 mL For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0643-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.5 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0642-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.25 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0641-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0640-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0639-2017Class ITerminatedApr 12, 2017Vancomycin Hydrochloride for InjectionPresence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.Hospira Inc., A Pfizer Company · D-0638-2017Class ITerminatedApr 12, 2017Ibuprofen Lysine InjectionPresence of Particulate MatterX-Gen Pharmaceuticals Inc. · D-0637-2017Class IIITerminatedApr 12, 2017Ciclopirox Olamine Cream USPLabeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.G & W Laboratories, Inc. · D-0636-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0635-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0634-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0633-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0632-2017Class IIITerminatedApr 12, 2017Nifedipine Extended-Release TabletsCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0631-2017Class IIITerminatedApr 12, 2017Nifedipine Extended-Release TabletsCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0630-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0629-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0628-2017Class IIITerminatedApr 12, 2017Nifedipine Extended-Release TabletsCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0627-2017Class IIOngoingApr 12, 2017Ventolin HFADefective Delivery System: Elevated number of units with out of specification results for leak rate.GlaxoSmithKline, LLC · D-0626-2017Class IITerminatedApr 12, 2017KalbitorPresence of Particulate Matter: GlassShire · D-0625-2017Class IITerminatedApr 5, 2017Sensodyne Repair & Protect WhiteningPresence of Foreign Substance; low concentration of an additional flavoring ingredient, Patchouli oil resulting in complaints of off flavor/scentGSK Consumer Healthcare · D-0624-2017Class IIITerminatedApr 5, 2017Montelukast sodium tabletsDiscoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.Hetero USA Inc · D-0623-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-0622-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0621-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0620-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0619-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0618-2017Class IITerminatedApr 5, 2017Divalproex Sodium Delayed Release TabletsFailed Dissolution Specifications; 9 month long term stabilityZydus Pharmaceuticals USA Inc · D-0617-2017Class IITerminatedApr 5, 2017Metronidazole InjectionLack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the...Claris Lifesciences Inc · D-0616-2017Class IITerminatedApr 5, 2017Levofloxacin Injection in 5% DextroseLack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the...Claris Lifesciences Inc · D-0615-2017Class IITerminatedApr 5, 2017Fluconazole InjectionLack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the...Claris Lifesciences Inc · D-0614-2017